TY - JOUR
T1 - Diacylglycerol kinase-α mediates hepatocyte growth factor-induced epithelial cell scatter by regulating rac activation and membrane ruffling
AU - Chianale, Federica
AU - Cutrupi, Santina
AU - Rainero, Elena
AU - Baldanzi, Gianluca
AU - Porporato, Paolo E.
AU - Traini, Sara
AU - Filigheddu, Nicoletta
AU - Gnocchi, Viola F.
AU - Santoro, Massimo M.
AU - Parolini, Ornella
AU - Van Blitterswijk, Wim J.
AU - Sinigaglia, Fabiola
AU - Graziani, Andrea
PY - 2007/12
Y1 - 2007/12
N2 - Diacylglycerol kinases (Dgk) phosphorylate diacylglycerol (DG) to phosphatidic acid (PA), thus turning off and on, respectively, DG-mediated and PA-mediated signaling pathways. We previously showed that hepatocyte growth factor (HGF), vascular endothelial growth factor, and anaplastic lymphoma kinase activate Dgkα in endothelial and leukemia cells through a Src-mediated mechanism and that activation of Dgkα is required for chemotactic, proliferative, and angiogenic signaling in vitro. Here, we investigate the downstream events and signaling pathways regulated by Dgkα, leading to cell scatter and migration upon HGF treatment and v-Src expression in epithelial cells. We report that specific inhibition of Dgkα, obtained either pharmacologically by R59949 treatment, or by expression of Dgkα dominant-negative mutant, or by small interfering RNA-mediated down-regulation of endogenous Dgkα, impairs 1) HGF- and v-Src-induced cell scatter and migration, without affecting the loss of intercellular adhesions; 2) HGF-induced cell spreading, lamellipodia formation, membrane ruffling, and focal adhesions remodeling; and 3) HGF-induced Rac activation and membrane targeting. In summary, we provide evidence that Dgkα, activated downstream of tyrosine kinase receptors and Src, regulates crucial steps directing Rac activation and Rac-dependent remodeling of actin cytoskeleton and focal contacts in migrating epithelial cells.
AB - Diacylglycerol kinases (Dgk) phosphorylate diacylglycerol (DG) to phosphatidic acid (PA), thus turning off and on, respectively, DG-mediated and PA-mediated signaling pathways. We previously showed that hepatocyte growth factor (HGF), vascular endothelial growth factor, and anaplastic lymphoma kinase activate Dgkα in endothelial and leukemia cells through a Src-mediated mechanism and that activation of Dgkα is required for chemotactic, proliferative, and angiogenic signaling in vitro. Here, we investigate the downstream events and signaling pathways regulated by Dgkα, leading to cell scatter and migration upon HGF treatment and v-Src expression in epithelial cells. We report that specific inhibition of Dgkα, obtained either pharmacologically by R59949 treatment, or by expression of Dgkα dominant-negative mutant, or by small interfering RNA-mediated down-regulation of endogenous Dgkα, impairs 1) HGF- and v-Src-induced cell scatter and migration, without affecting the loss of intercellular adhesions; 2) HGF-induced cell spreading, lamellipodia formation, membrane ruffling, and focal adhesions remodeling; and 3) HGF-induced Rac activation and membrane targeting. In summary, we provide evidence that Dgkα, activated downstream of tyrosine kinase receptors and Src, regulates crucial steps directing Rac activation and Rac-dependent remodeling of actin cytoskeleton and focal contacts in migrating epithelial cells.
UR - http://www.scopus.com/inward/record.url?scp=37049030418&partnerID=8YFLogxK
U2 - 10.1091/mbc.E07-02-0177
DO - 10.1091/mbc.E07-02-0177
M3 - Article
SN - 1059-1524
VL - 18
SP - 4859
EP - 4871
JO - Molecular Biology of the Cell
JF - Molecular Biology of the Cell
IS - 12
ER -